Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      Voluntary recall of several medicines containing valsartan due to impurity: FDA

      Voluntary recall of several medicines containing valsartan due to impurity: FDA

      Ruby Khatun Khatun17 July 2018 9:45 AM IST
      The U.S. Food and Drug Administration (FDA) is alerting healthcare professionals and patients of a voluntary recall of several drug products...
      OPPI launches campaign calling for ideas to improve healthcare

      OPPI launches campaign calling for ideas to improve healthcare

      Ruby Khatun Khatun17 July 2018 9:30 AM IST
      New Delhi: Industry body Organisation of Pharmaceutical Producers of India (OPPI) launched a digital campaign, ThinkForHealth, calling for ideas to...
      Fortis to be renamed as Gleneagles, says IHH Managing Director Tan See Leng

      Fortis to be renamed as Gleneagles, says IHH Managing Director Tan See Leng

      Ruby Khatun Khatun16 July 2018 1:21 PM IST
      "In the long term and going ahead we would like to rebrand the Fortis hospitals to our own brand, Gleneagles," stated IHH Managing Director and CEO...
      Dr Reddys to appeal restriction on sale of generic Suboxone film in US

      Dr Reddy's to appeal restriction on sale of generic Suboxone film in US

      Ruby Khatun Khatun16 July 2018 10:45 AM IST
      New Delhi: Pharma major Dr Reddy's Laboratories said it will appeal the decision of the US District Court of New Jersey regarding further sales and...
      Aurobindo to buy Apotex in 5 European nations for 74 million euros

      Aurobindo to buy Apotex in 5 European nations for 74 million euros

      Ruby Khatun Khatun16 July 2018 10:18 AM IST
      New Delhi: Aurobindo Pharma said it has inked a pact to acquire Apotex's commercial operations across five European countries, including Poland and...
      Mitra Biotech raises Rs 270 crores funding from Northpond Ventures

      Mitra Biotech raises Rs 270 crores funding from Northpond Ventures

      Ruby Khatun Khatun16 July 2018 10:05 AM IST
      BOSTON and Bengaluru: Mitra RxDx (dba Mitra Biotech), a privately held biotech company and global leader in advancing truly personalized oncology...
      Drug for chemotherapy-induced nausea launched in India, Nepal

      Drug for chemotherapy-induced nausea launched in India, Nepal

      Ruby Khatun Khatun16 July 2018 10:00 AM IST
      Akynzeo is an oral fixed combination of netupitant 300 mg and palonosetron 0.5 mg. New Delhi: Glenmark Pharmaceuticals launched Akynzeo, a drug used...
      China pushes for lower cancer drug prices

      China pushes for lower cancer drug prices

      Ruby Khatun Khatun16 July 2018 9:45 AM IST
      SHANGHAI: China’s new medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of...
      Johnson and Johnson vows to overturn 4.7 billion dollar talc verdict but experts see hurdles

      Johnson and Johnson vows to overturn 4.7 billion dollar talc verdict but experts see hurdles

      Ruby Khatun Khatun16 July 2018 9:30 AM IST
      NEW YORK: Johnson and Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who claim asbestos-contaminated talc in the company’s...
      Stronger Warning for fluoroquinolone antibiotics added by FDA

      Stronger Warning for fluoroquinolone antibiotics added by FDA

      Ruby Khatun Khatun15 July 2018 11:45 AM IST
      FDA-approved fluoroquinolones include levofloxacin (Levaquin), ciprofloxacin (Cipro), ciprofloxacin extended-release tablets, moxifloxacin (Avelox),...
      Lupin gets USFDA approval to market antibacterial capsules

      Lupin gets USFDA approval to market antibacterial capsules

      Ruby Khatun Khatun15 July 2018 10:45 AM IST
      New Delhi: Drug firm Lupin said it has received final approval from the US health regulator to market its antibacterial Nitrofurantoin capsules used...
      Cipla subsidiary to acquire South Africa’s Mirren for Rs 228 crore

      Cipla subsidiary to acquire South Africa’s Mirren for Rs 228 crore

      Ruby Khatun Khatun15 July 2018 10:30 AM IST
      New Delhi: Drug major Cipla's subsidiary has signed an agreement to fully acquire South Africa's Mirren (Pty) Ltd for a cash consideration of South...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok